Part of

Antibodies

CancerTools offers a wide range of monoclonal, polyclonal and recombinant antibodies, for research in DNA damage and repair, proliferation, regulated cell death, cell signalling and adhesion, tumour microenvironment, inflammation and immunophenotyping.

To meet your needs, we offer customised formulations of our antibody collection, including carrier-free. If you need to scale up your project or can’t find the right combination of antibody and label of interest, our antibodies can also be ordered in large volumes and/or with customised conjugation, giving the flexibility you need for your experiments.

Showing 2101–2125 of 2177 results

Cat. #

Tool Name

161748

anti-SARS-COV-2-SPIKE1 3B11/B11/A3/A8

Cat. #:	161748
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	Spike1 but not RBD sensitive
Class:	Monoclonal
Reactivity:	Â
Host:	Mouse

161749

anti-SARS-COV-2-SPIKE1 3B11/B11/A3/B6

Cat. #:	161749
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	Spike1 but not RBD sensitive
Class:	Monoclonal
Reactivity:	Â
Host:	Mouse

161750

anti-SARS-COV-2-SPIKE1 5F4/A9/G3/A1

Cat. #:	161750
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	Spike 1 RBD sensitive
Class:	Monoclonal
Reactivity:	Â
Host:	Mouse

161751

anti-SARS-COV-2-SPIKE1 5F4/A9/G3/B11

Cat. #:	161751
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	Spike 1 RBD sensitive
Class:	Monoclonal
Reactivity:	Â
Host:	Mouse

161942

Anti-BTRC (3A2F11A12)

Cat. #:	161942
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	BTRC
Class:	Monoclonal
Application:	WB, IF
Reactivity:	Human
Host:	Mouse

161941

Anti-ZNF410 (5E3F9H9)

Cat. #:	161941
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	ZNF410
Class:	Monoclonal
Application:	WB, IF
Reactivity:	Human
Host:	Mouse

161944

Anti-KCMF1 (7G2C11G2)

Cat. #:	161944
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	KCMF1
Class:	Monoclonal
Application:	WB, IF
Reactivity:	Human
Host:	Mouse

161943

Anti-HOXb8 (1D6G6G7)

Cat. #:	161943
Sub-type:	Primary antibody
Availability:	3-4 weeks
Target:	HOXB8
Class:	Monoclonal
Application:	WB, IF
Reactivity:	Human
Host:	Mouse

162127

Anti-Laminin alpha 5 [8G9]

Cat. #:	162127
Availability:	3-4 weeks
Target:	Laminin alpha 5
Class:	Monoclonal
Application:	ELISA ; IHC
Reactivity:	Human
Host:	Mouse

162128

Anti-Laminin alpha 5 [4B12]

Cat. #:	162128
Availability:	3-4 weeks
Target:	Laminin alpha 5
Class:	Monoclonal
Application:	IF/ICC
Reactivity:	Human
Host:	Mouse

162129

Anti-Laminin alpha 4 [3H2]

Cat. #:	162129
Availability:	3-4 weeks
Target:	Laminin alpha 4
Class:	Monoclonal
Application:	IP (not suitable for WB)
Reactivity:	Human
Host:	Mouse

162207

Anti-HSPB1p82 [1.2]

Cat. #:	162207
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	human heat shock protein 27 phosphorylated at site 82, HSP27p82; mouse heat shock protein 27 phosphorylated at site 86, HSP27p86
Class:	Monoclonal
Application:	WB ; IP ; IHC
Reactivity:	human, mouse, rat, hamster, dog, chick

162208

Anti-HSPB1p78 [2.1]

Cat. #:	162208
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	human heat shock protein 27 phosphorylated at site 78, HSP27p78
Class:	Monoclonal
Application:	WB ; IP ; IHC
Reactivity:	Human

162209

Anti-HSPB1p82 [1.4]

Cat. #:	162209
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	human heat shock protein 27 phosphorylated at site 82, HSP27p82; mouse heat shock protein 27 phosphorylated at site 86, HSP27p86
Class:	Monoclonal
Application:	WB ; IP ; IHC
Reactivity:	human, mouse, rat, hamster, dog, chick

162210

Cat. #:	162210
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	human heat shock protein 27, HSP27
Class:	Polyclonal
Application:	WB
Reactivity:	Human

162211

Anti-HSPB1p15 PAb

Cat. #:	162211
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	human heat shock protein 27 phosphorylated at site 15, HSP27p15; mouse heat shock protein 27 phosphorylated at site 15, HSP27p15
Class:	Polyclonal
Application:	WB
Reactivity:	Human

162212

Cat. #:	162212
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	glial fibrillary acidic protein GFAP
Class:	Polyclonal
Application:	WB ; IP ; IHC
Reactivity:	Human

162213

Cat. #:	162213
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	glial fibrillary acidic protein GFAP
Class:	Polyclonal
Application:	WB ; IP ; IHC
Reactivity:	Human

162214

Cat. #:	162214
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	HSPB3
Class:	Polyclonal
Application:	WB ; IHC
Reactivity:	Human

162215

Cat. #:	162215
Sub-type:	Primary antibody
Unit Size:	100 ug
Availability:	3-4 weeks
Target:	HSPB4
Class:	Polyclonal
Application:	WB ; IHC
Reactivity:	Human, rat

162347

Anti-cytoplasmic tail of CD4 [8A5]

Cat. #:	162347
Sub-type:	Primary antibody
Unit Size:	100 ug
Target:	RFLPADQMNVADPQPLASCS of human CD4
Application:	ELISA
Reactivity:	Human
Host:	Mouse

162348

Anti-CD4 past the UGA codon

Cat. #:	162348
Sub-type:	Primary antibody
Unit Size:	100 ug
Application:	ELISA
Reactivity:	Human
Host:	Mouse

162374

Anti-Bop1 monoclonal antibody [BOP 6H11]

Cat. #:	162374
Sub-type:	Primary antibody
Target:	Human Block of Proliferation 1 (BOP1)
Class:	Monoclonal
Application:	WB
Reactivity:	Human
Host:	Rat

162375

Anti-PAX9 monoclonal antibody [PAX9 7C2]

Cat. #:	162375
Sub-type:	Primary antibody
Target:	Human/murine PAX9
Class:	Monoclonal
Application:	WB
Reactivity:	Human, mouse
Host:	Rat

162376

Anti-primase p58 monoclonal antibody [PRI-5G6]

Cat. #:	162376
Sub-type:	Primary antibody
Target:	Human primase p58
Class:	Monoclonal
Application:	WB
Reactivity:	Human
Host:	Rat

1 … 84 85 86 … 88

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.